Main
>
ONCOLOGY (**)
>
Lymphoma>HL>Classical>Stage 3/4>+
>
TREAT.:
>
Co: USA. S. BrentuxiMAb Vedotin>+
>
(*) USA Approval Date: 2018. 03.
(*) USA Approval Date: 2018. 03.'s products
This section has no products